14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of TGTX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

TG Therapeutics stock downgraded from Buy Candidate to Hold/Accumulate after Friday trading session.
(Updated on May 03, 2024)

Buy or Hold candidate since May 01, 2024 Gain 1.95% PDF

The TG Therapeutics stock price fell by -1.40% on the last day (Friday, 3rd May 2024) from $16.42 to $16.19. During the last trading day the stock fluctuated 6.52% from a day low at $15.96 to a day high of $17.00. The price has been going up and down for this period, and there has been a 17.49% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -4 million shares and in total, 5 million shares were bought and sold for approximately $77.24 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -3.78% during the next 3 months and, with a 90% probability hold a price between $11.98 and $17.10 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

TGTX Signals & Forecast

The TG Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $14.69 and $14.71. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, May 02, 2024, and so far it has fallen -1.40%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for TG Therapeutics stock

TG Therapeutics finds support from accumulated volume at $15.88 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.04 between high and low, or 6.52%. For the last week, the stock has had daily average volatility of 9.26%.

Our recommended stop-loss: $15.52 (-4.13%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (TGTX) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect TG Therapeutics to open at $16.38, and during the day (based on 14 day Average True Range), to move between $15.24 and $17.14, which gives a possible trading interval of +/-$0.95 (+/-5.85%) up or down from last closing price. If TG Therapeutics takes out the full calculated possible swing range there will be an estimated 11.70% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $16.42 (1.42%) than the support at $15.88 (1.91%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is TG Therapeutics stock A Buy?

TG Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.684 Hold/Accumulate Downgraded

Predicted Opening Price for TG Therapeutics of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
$16.38 ( 1.19%) $16.19

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TGTX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 17.42 7.62 %
R2 17.03 5.16 %
R1 16.78 3.65 %
Current price: 16.19
Support S1 15.99 -1.26 %
S2 15.74 -2.78 %
S3 15.34 -5.23 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 17.63 8.89 %
R2 17.22 6.36 %
R1 16.42 1.42 %
Current price 16.19
Support S1 15.88 -1.91%
S2 15.31 -5.44%
S3 13.91 -14.08%

FAQ

What is the symbol for TG Therapeutics Stock and on which exchange is it traded?
The symbol for TG Therapeutics is TGTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell TG Therapeutics Stock?
TG Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy TG Therapeutics Stock?
TG Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy TG Therapeutics Stock.

What's the current price of TG Therapeutics Stock?
As of the end of day on the May 03, 2024, the price of an TG Therapeutics (TGTX) share was $16.19.

What is the 52-week high and low for TG Therapeutics Stock?
The 52-week high for TG Therapeutics Stock is $35.67 and the 52-week low is $6.47.

What is the market capitalization of TG Therapeutics Stock?
As of the May 03, 2024, the market capitalization of TG Therapeutics is 2.502B.

When is the next earnings date for TG Therapeutics?
The upcoming earnings date for TG Therapeutics is Aug 06, 2024.
Click to get the best stock tips daily for free!

About TG Therapeutics

TG Therapeutics TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and relapsing forms of multiple sclerosis; and Umbra... TGTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT